Literature DB >> 26276673

Cornin increases angiogenesis and improves functional recovery after stroke via the Ang1/Tie2 axis and the Wnt/β-catenin pathway.

Yangyang Xu1, Guanghua Zhang1, Zechun Kang1, Yong Xu1, Wangling Jiang2, Shuping Zhang3.   

Abstract

We investigated whether cornin, an iridoid glycoside isolated from fruits of Verbena officinalis L., regulated angiogenesis and thereby improved functional outcomes after stroke and discovered a potential mechanism. The effects of cornin on proliferation of rat artery smooth muscle cell (RASMC) and signalling was investigated in vitro. Adult male rats were subjected to 1 h of middle cerebral artery occlusion (MCAO) and reperfusion and treated with or without 25 mg/kg of cornin, starting 24 h after ischemia and reperfusion, by continuous intravenous injection daily for 14 days. Neurological functional tests were performed and cerebral Evans blue extravasation was measured. Angiogenesis and angiogenic factor expressions were measured by immunohistochemistry and Western blotting, respectively. Cornin increased the proliferation of RASMC and enhanced the expression of Wnt5a, β-catenin, cyclin D1 and angiopoietin-1 (Ang1). Cornin treatment promoted angiogenesis in the ischemic brain core and improved functional outcomes after stroke. Cornin-treated MCAO rats showed significant increase in vascularization and expression of vascular endothelial growth factor and Ang1 and phosphorylation of Tie2 and Akt compared with vehicle-treated MCAO rats. The Ang1/Tie2 axis and Wnt/β-catenin pathways appear to mediate cornin-induced angiogenesis.

Entities:  

Keywords:  Ang1/Tie2; Angiogenesis; Cornin; VEGF; Wnt/β-catenin

Mesh:

Substances:

Year:  2015        PMID: 26276673     DOI: 10.1007/s12272-015-0652-1

Source DB:  PubMed          Journal:  Arch Pharm Res        ISSN: 0253-6269            Impact factor:   4.946


  8 in total

1.  Morin Attenuated Cerebral Ischemia/Reperfusion Injury Through Promoting Angiogenesis Mediated by Angiopoietin-1-Tie-2 Axis and Wnt/β-Catenin Pathway.

Authors:  Satchakorn Khamchai; Wijitra Chumboatong; Janejira Hata; Chainarong Tocharus; Apichart Suksamrarn; Jiraporn Tocharus
Journal:  Neurotox Res       Date:  2022-01-08       Impact factor: 3.911

2.  Insulin and liraglutide attenuate brain pathology in diabetic mice by enhancing the Wnt/β-catenin signaling pathway.

Authors:  Yuan Zhao; Jie Yu; Fan Ping; Lingling Xu; Wei Li; Huabing Zhang; Yuxiu Li
Journal:  Exp Ther Med       Date:  2022-05-11       Impact factor: 2.751

Review 3.  Primary cilia and ciliary signaling pathways in aging and age-related brain disorders.

Authors:  Rong Ma; Naseer A Kutchy; Liang Chen; Douglas D Meigs; Guoku Hu
Journal:  Neurobiol Dis       Date:  2021-12-31       Impact factor: 7.046

Review 4.  Glia and Neural Stem and Progenitor Cells of the Healthy and Ischemic Brain: The Workplace for the Wnt Signaling Pathway.

Authors:  Tomas Knotek; Lucie Janeckova; Jan Kriska; Vladimir Korinek; Miroslava Anderova
Journal:  Genes (Basel)       Date:  2020-07-16       Impact factor: 4.096

5.  Wnt canonical pathway activator TWS119 drives microglial anti-inflammatory activation and facilitates neurological recovery following experimental stroke.

Authors:  Degang Song; Xiangjian Zhang; Junmin Chen; Xiaoxia Liu; Jing Xue; Lan Zhang; Xifa Lan
Journal:  J Neuroinflammation       Date:  2019-12-06       Impact factor: 8.322

6.  Cornin protects SH‑SY5Y cells against oxygen and glucose deprivation‑induced autophagy through the PI3K/Akt/mTOR pathway.

Authors:  Changling Ding; Jie Zhang; Baoyuan Li; Zhaoxing Ding; Wenna Cheng; Fei Gao; Ye Zhang; Yangyang Xu; Shuping Zhang
Journal:  Mol Med Rep       Date:  2017-10-25       Impact factor: 2.952

7.  Screening circular RNA expression patterns following focal cerebral ischemia in mice.

Authors:  Cuiying Liu; Chencheng Zhang; Jian Yang; Xiaokun Geng; Huishan Du; Xunming Ji; Heng Zhao
Journal:  Oncotarget       Date:  2017-09-23

8.  Scalp Electroacupuncture Promotes Angiogenesis after Stroke in Rats by Activation of Wnt/β-Catenin Signal Pathway.

Authors:  Shuai Shi; Mingye Wang; Xiaofang Liu; Shengwang Han; Pengyu Zhu
Journal:  Evid Based Complement Alternat Med       Date:  2022-03-14       Impact factor: 2.629

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.